<![CDATA[Biotek-snakken — April 2023]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/topic/401430/biotek-snakken-april-2023RSS for NodeSun, 07 Jun 2026 03:19:30 GMTSat, 01 Apr 2023 02:31:43 GMT60<![CDATA[Reply to Biotek-snakken — April 2023 on Sun, 30 Apr 2023 02:28:49 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8065873https://dev.proinvestor.com/forum/post/8065873Sun, 30 Apr 2023 02:28:49 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Sat, 29 Apr 2023 04:17:52 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8065871https://dev.proinvestor.com/forum/post/8065871Sat, 29 Apr 2023 04:17:52 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Fri, 28 Apr 2023 05:33:08 GMT]]>Og det ligner computerhandler med meget små antal stk, og kunne være noget algoritme handel. Møgirriterende at se på.

]]>https://dev.proinvestor.com/forum/post/8065869https://dev.proinvestor.com/forum/post/8065869Fri, 28 Apr 2023 05:33:08 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Fri, 28 Apr 2023 05:21:48 GMT]]>Alle stigninger i XBrane bliver ihvertfald skudt lynhurtigt ned igen. Ser meget underligt ud.

]]>https://dev.proinvestor.com/forum/post/8065868https://dev.proinvestor.com/forum/post/8065868Fri, 28 Apr 2023 05:21:48 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Fri, 28 Apr 2023 02:26:26 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8065872https://dev.proinvestor.com/forum/post/8065872Fri, 28 Apr 2023 02:26:26 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Fri, 28 Apr 2023 01:43:42 GMT]]>MarkCap på 1.6 mia DKK.. pipeline med Cimzia, Opdivo, Keytruda, Darzalex.. alle indenfor de næste 8 år.. og med samlet salg idag på 200 mia DKK. Samt med udvomk på 1/10-1/20 af et novel drug og succesrate på 78%.. burde være en oplagt investering med en markedsværdi langt højere, ovenstående taget i betragtning.

]]>https://dev.proinvestor.com/forum/post/8065866https://dev.proinvestor.com/forum/post/8065866Fri, 28 Apr 2023 01:43:42 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Fri, 28 Apr 2023 01:32:28 GMT]]>Aps. Kan ikke rigtigt lure, hvorfor kursen sejler som den gør.. og hvorfor den synes at skulle ligge omkring 90.. synes casen enorm stærk, pipeline med lille risiko og stærk platform.. fremtiden er kun lysere, eftersom US er ved at komme efter biosimilars og presset på medicin priser. Hvis de kun havde dette ene stof, kan jeg forstå kursen.. men som langsigtet investor er selskabet mange gange mere værd.

]]>https://dev.proinvestor.com/forum/post/8065870https://dev.proinvestor.com/forum/post/8065870Fri, 28 Apr 2023 01:32:28 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 11:41:04 GMT]]>Kort video - Pharma og biotek-opdatering UGE 17: Demant ' GN Store Nord ' Novo Nordisk ' Genmab ' Zealand Pharma ' Hansa Biopharma https://www.proinvestor.com/boards/112327

]]>https://dev.proinvestor.com/forum/post/8065874https://dev.proinvestor.com/forum/post/8065874Thu, 27 Apr 2023 11:41:04 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 07:16:07 GMT]]>Jazz, Endelig lidt medvind til XBrane, efter nogle MEGET mærkelige kursudsving. Tænker også lidt at Biden`s udtalelser om for dyre medicin priser i USA, burde give biosimilarer medvind, da de giver store besparelser på prisen. Eller, hvad tænker du?

]]>https://dev.proinvestor.com/forum/post/8065863https://dev.proinvestor.com/forum/post/8065863Thu, 27 Apr 2023 07:16:07 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 06:19:49 GMT]]>Allogene Therapeutics Announces Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting
https://firstwordpharma.com/story/5732508

]]>https://dev.proinvestor.com/forum/post/8065865https://dev.proinvestor.com/forum/post/8065865Thu, 27 Apr 2023 06:19:49 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 06:17:49 GMT]]>BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues https://firstwordpharma.com/story/5732666?nle=113791&nlc=30

]]>https://dev.proinvestor.com/forum/post/8065864https://dev.proinvestor.com/forum/post/8065864Thu, 27 Apr 2023 06:17:49 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 06:17:07 GMT]]>Precigen to Present Latest Clinical Advancements for PRGN-3005 UltraCAR-T and PRGN-2009 Off-the-Shelf AdenoVerse Immunotherapy at the 2023 ASCO Annual Meeting https://firstwordpharma.com/story/5732708

]]>https://dev.proinvestor.com/forum/post/8065861https://dev.proinvestor.com/forum/post/8065861Thu, 27 Apr 2023 06:17:07 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 03:31:16 GMT]]>LP90, ja den er satme trist, og godt nok en uvenlig måde at sætte prisen på for de mindre aktionære. Men for de store som har garanteret emissionen og kan supplere er det jo fint.

]]>https://dev.proinvestor.com/forum/post/8065867https://dev.proinvestor.com/forum/post/8065867Thu, 27 Apr 2023 03:31:16 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 03:21:47 GMT]]>Bergenbio er godt nok blevet et meget uheldigt bekendtskab rigtig rigtig dyrt

]]>https://dev.proinvestor.com/forum/post/8065857https://dev.proinvestor.com/forum/post/8065857Thu, 27 Apr 2023 03:21:47 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 03:18:10 GMT]]>Godmorgen 🙂

]]>https://dev.proinvestor.com/forum/post/8065859https://dev.proinvestor.com/forum/post/8065859Thu, 27 Apr 2023 03:18:10 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 02:34:31 GMT]]>Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis https://ml-eu.globenewswire.com/Resource/Download/b746af4d-f81a-41ed-a2dc-8a2ac59bd5f7

]]>https://dev.proinvestor.com/forum/post/8065860https://dev.proinvestor.com/forum/post/8065860Thu, 27 Apr 2023 02:34:31 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Thu, 27 Apr 2023 01:53:28 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8065853https://dev.proinvestor.com/forum/post/8065853Thu, 27 Apr 2023 01:53:28 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Wed, 26 Apr 2023 10:33:19 GMT]]>....og dermed massakrerer DNB sitt kursmål med nesten 90% (!), fra NOK 9 til NOK 1 og nedgraderer til selg. Xtrainvestor

]]>https://dev.proinvestor.com/forum/post/8065858https://dev.proinvestor.com/forum/post/8065858Wed, 26 Apr 2023 10:33:19 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Wed, 26 Apr 2023 10:32:55 GMT]]>BERGENBIO: Selskapet meldte etter børs at de foreslår en fortrinnsrettsemisjon på 250 MNOK. 175 MNOK er garantert og gir et garantihonorar på 12%. Forslaget må godkjennes av generalforsamlingen og tegningskursen skal være den teoretiske
ex-rettighetskursen (TERP) basert på volumvektet gjennomsnittspris (VWAP) på selskapets aksjer på Oslo Børs de tre handelsdagene før generalforsamlingen fratrukket en rabatt på minst 37,5 %.

]]>https://dev.proinvestor.com/forum/post/8065862https://dev.proinvestor.com/forum/post/8065862Wed, 26 Apr 2023 10:32:55 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Wed, 26 Apr 2023 02:28:58 GMT]]>Godmorgen...

]]>https://dev.proinvestor.com/forum/post/8065855https://dev.proinvestor.com/forum/post/8065855Wed, 26 Apr 2023 02:28:58 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Wed, 26 Apr 2023 02:20:49 GMT]]>FDA Grants Accelerated Approval For
Biogen's ALS Drug https://www.proinvestor.com/investornyt/973749/fda-grants-accelerated-approval-for-biogens-als-drug

]]>https://dev.proinvestor.com/forum/post/8065856https://dev.proinvestor.com/forum/post/8065856Wed, 26 Apr 2023 02:20:49 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Tue, 25 Apr 2023 18:26:52 GMT]]>XBrane…Ja, Jazz, hvis NHS aftalen alene vurderes til at give XBrane 160 mill. I nettoindtægter over de næste 12 mnd, så venter der godt nok spændende tider, når først Ximluci bliver bredt helt ud,i europa, og sikkert også USA næste år. Ansøgning til FDA i USA er jo indsendt og går nok igennem sidst på året, eller Q1 2024. 🙂 Det ser rigtig spændende ud.

]]>https://dev.proinvestor.com/forum/post/8065849https://dev.proinvestor.com/forum/post/8065849Tue, 25 Apr 2023 18:26:52 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Tue, 25 Apr 2023 15:00:10 GMT]]>.... "Upfront Consideration Represents a Premium of 65% and the Total Potential Consideration Represents a Premium of 94% to Spectrum’s Latest Closing Price"

]]>https://dev.proinvestor.com/forum/post/8065854https://dev.proinvestor.com/forum/post/8065854Tue, 25 Apr 2023 15:00:10 GMT<![CDATA[Reply to Biotek-snakken — April 2023 on Tue, 25 Apr 2023 14:59:08 GMT]]>"Spectrum Pharmaceuticals"

Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction

Link Preview Image
Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction

Complementary Commercial Growth Platforms Anticipated to Accelerate ROLVEDON™ (eflapegrastim-xnst) Injection Profitability and Diversify Revenue Streams Combination of Assertio’s Omni-Channel Digital Sales Capabilities and ROLVEDON In-Person Commercial Team to Enhance Market Access and Growth across All Products Transaction Expected to Be Accretive to Assertio’s Adjusted EPS and Operating Cash Flow in 2024 Spectrum Stockholders Will Receive Upfront Consideration of 0.1783 ASRT shares per SPPI Sh

favicon

Yahoo Finance (finance.yahoo.com)

]]>https://dev.proinvestor.com/forum/post/8065852https://dev.proinvestor.com/forum/post/8065852Tue, 25 Apr 2023 14:59:08 GMT